The White House is indefinitely postponing its selection of a permanent Centers for Disease Control and Prevention director, leaving acting head Jay Bhattacharya overseeing the agency past a key deadline.
Why it matters: The punt underscores the difficulty of finding a nominee who can be confirmed by the Senate and leaves the beleaguered public health agency without a full-time political leader.
A leading anti-vaccine activist is petitioning the Department of Health and Human Services to add more than 300 conditions to a table used for vaccine injury compensation claims — and is threatening to sue the agency if it doesn't.
Why it matters: The effort is led by vaccine-injury lawyer Aaron Siri, a longtime ally of Health Secretary Robert F. Kennedy Jr., who was invited to brief a vaccine advisory committee in December on the childhood immunization schedule.
Multiple high-level vacancies at federal health agencies are giving the Trump administration a chance to pivot from contentious vaccine policies to a more mainstream public health strategy.
Why it matters: The anticipated nomination of a new Centers for Disease Control and Prevention director and selection of a top Food and Drug Administration vaccine regulator will be closely watched for signs the White House wants to break from the drama that characterized much of the past year.
CarMax's financial analysts and Instacart's software engineers rank among the top roles in an index, out Tuesday, that rates U.S. employers on how well they support workers' upward mobility.
Why it matters: Where you work increasingly determines whether you'll get promoted or get stuck. This first "Where You Work Matters" list is designed to reward employers who help workers move up and expose those who don't.
The ratings of 1,750 employers (across 55,000 occupations) were assembled by the Schultz Family Foundation and the Burning Glass Institute, in partnership with Harvard Business School's Managing the Future of Work Project.
The Trump administration's suspension of certain immigrants' work authorization renewals is sidelining possibly thousands offoreign-born doctors, some of the affected physicians tell Axios.
Why it matters: The policy could worsen access to care in a health system already facing physician shortages.
